Acuity Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Acuity Inc. AYI | 0.00 |
Shareholders of Acuity Inc. (NYSE:AYI) will be pleased this week, given that the stock price is up 13% to US$362 following its latest third-quarter results. Acuity reported US$1.2b in revenue, roughly in line with analyst forecasts, although statutory earnings per share (EPS) of US$4.56 beat expectations, being 8.1% higher than what the analysts expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Following the latest results, Acuity's eight analysts are now forecasting revenues of US$4.88b in 2027. This would be an okay 6.0% improvement in revenue compared to the last 12 months. Per-share earnings are expected to swell 14% to US$18.09. Before this earnings report, the analysts had been forecasting revenues of US$4.85b and earnings per share (EPS) of US$17.66 in 2027. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.
The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 13% to US$397. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Acuity, with the most bullish analyst valuing it at US$465 and the most bearish at US$358 per share. This is a very narrow spread of estimates, implying either that Acuity is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Acuity's past performance and to peers in the same industry. We can infer from the latest estimates that forecasts expect a continuation of Acuity'shistorical trends, as the 4.8% annualised revenue growth to the end of 2027 is roughly in line with the 4.4% annual growth over the past five years. Compare this with the broader industry (in aggregate), which analyst estimates suggest will see revenues grow 14% annually. So it's pretty clear that Acuity is expected to grow slower than similar companies in the same industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Acuity following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Acuity's revenue is expected to perform worse than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.
With that in mind, we wouldn't be too quick to come to a conclusion on Acuity. Long-term earnings power is much more important than next year's profits. We have forecasts for Acuity going out to 2028, and you can see them free on our platform here.
It might also be worth considering whether Acuity's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
